Heart check revolution: new models may spare thousands from unneeded scans
NCT ID NCT06708000
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether personalized risk models can safely reduce the number of diagnostic tests for people with new chest pain. Researchers will enroll 2,000 adults aged 30-75 and compare the model-based approach to standard care. They will also test a new laser method to measure blood flow in tiny vessels. The goal is to see if patients stay symptom-free and avoid unnecessary procedures.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Clinical Likelihood (CL) Model-Based Diagnostic Strategy
What this could lead to
If successful, this could help doctors use fewer invasive tests for chest pain, saving time and discomfort for many patients.
What could go wrong
This is a large Phase 3 trial, but the approach may not be accurate for all patient groups, and the new laser test is still experimental.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Regional Hospital of Godstrup
Herning, 7400, Denmark